When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t ...
In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...